Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10026)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2018 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A. Osteoporosis in primary biliary cholangitis. World J Gastroenterol 2018; 24(31): 3513-3520 [PMID: 30131657 DOI: 10.3748/wjg.v24.i31.3513] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i31/3513.htm |
| Number | Citing Articles |
| 1 |
Jia-Liang Chen, Yao Liu, Yu-Fei Bi, Xian-Bo Wang. Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis. World Journal of Gastroenterology 2023; 29(29): 4580-4592 doi: 10.3748/wjg.v29.i29.4580
Abstract(660) |
Core Tip(677) |
Full Article(HTML)(2237)
|
Full Article with Cover (PDF)-1288K(105)
|
Full Article (Word)-533K(46)
|
Audio-671K(3)
|
Peer-Review Report-232K(70)
|
Answering Reviewers-160K(64)
|
Supplementary Material-143K(70)
|
Full Article (PDF)-866K(176)
|
Full Article (XML)-139K(66)
|
Times Cited (1)
|
Total Visits (8019)
|
Open
|
| 2 |
Tsai Yi-Liang. Osteoporosis, Osteoarthritis and Rheumatoid Arthritis: An Agonizing Skeletal Triad. 2023; : 1 doi: 10.2174/9789815196085123010004
|
| 3 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism for development of malnutrition in primary biliary cholangitis. World Journal of Meta-Analysis 2022; 10(3): 81-98 doi: 10.13105/wjma.v10.i3.81
|
| 4 |
Richard Pullen. A Clinical Review of Primary Biliary Cholangitis. Gastroenterology Nursing 2020; 43(2): E48 doi: 10.1097/SGA.0000000000000480
|
| 5 |
J. Jadzic, P. Milovanovic, N. Tomanovic, V. Zivkovic, D. Djukic, S. Nikolic, M. Djuric, D. Djonic. Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses. Journal of Endocrinological Investigation 2023; 47(1): 131 doi: 10.1007/s40618-023-02130-3
|
| 6 |
Young Joo Yang, Dong Joon Kim. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. International Journal of Molecular Sciences 2021; 22(5): 2604 doi: 10.3390/ijms22052604
|
| 7 |
Zaid Ansari, Ishani Shah, Abhishek Bhurwal, Harsh Mehta, Surabhi Uppal, Indu Srinivasan, Savio Reddymasu, Keng-Yu Chuang. Decreasing Rates of Fracture-Related Hospitalization With Primary Biliary Cholangitis: Insights From the Nationwide Inpatient Sample. Cureus 2022; doi: 10.7759/cureus.25001
|
| 8 |
Andrea A Gossard, Keith D. Lindor. Current and promising therapy for primary biliary cholangitis. Expert Opinion on Pharmacotherapy 2019; 20(9): 1161 doi: 10.1080/14656566.2019.1601701
|
| 9 |
M. Carbone, A. Gerussi, V. Cardinale, N. Cazzagon, V. Cossiga, A. Lleo, G. Marrone, M. Marzioni, A. Moschetta, L. Muratori, C. Rigamonti, U. Vespasiani-Gentilucci, M. Fraquelli, V. Calvaruso. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis. Digestive and Liver Disease 2024; 56(9): 1461 doi: 10.1016/j.dld.2024.05.002
|
| 10 |
Yuan Liu, Mengqin Yuan, Jian He, Longjiao Cai, Aimin Leng. The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study. Calcified Tissue International 2024; 114(5): 502 doi: 10.1007/s00223-024-01204-5
|
| 11 |
|
| 12 |
Sabrina Ehnert, Romina H. Aspera-Werz, Marc Ruoß, Steven Dooley, Jan G. Hengstler, Silvio Nadalin, Borna Relja, Andreas Badke, Andreas K. Nussler. Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development. International Journal of Molecular Sciences 2019; 20(10): 2555 doi: 10.3390/ijms20102555
|
| 13 |
Nicola Pugliese, Ivan Arcari, Alessio Aghemo, Andrea G Lania, Ana Lleo, Gherardo Mazziotti. Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges . World Journal of Gastroenterology 2022; 28(14): 1430-1443 doi: 10.3748/wjg.v28.i14.1430
|
| 14 |
Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Ariunzaya Tsedendamba, Slavomira Komarova, Peter Jarcuska. Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective. Gastroenterology Insights 2024; 15(2): 419 doi: 10.3390/gastroent15020030
|
| 15 |
Maja Mijic, Ivona Saric, Bozena Delija, Milos Lalovac, Nikola Sobocan, Eva Radetic, Dora Martincevic, Tajana Filipec Kanizaj, Alessandro Granito. Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/7831165
|
| 16 |
Leandro Sierra, Ana Marenco-Flores, Romelia Barba, Daniela Goyes, Bryan Ferrigno, Wilfor Diaz, Esli Medina-Morales, Behnam Saberi, Vilas R Patwardhan, Alan Bonder. Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. Annals of Hepatology 2024; 29(3): 101283 doi: 10.1016/j.aohep.2023.101283
|
| 17 |
Weize Gao, Chong Peng, Zhan Wang, Yongxin Li, Mingjun Liu. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05247-y
|
| 18 |
Yanyan Li, Bo Liu, Xin Li. High C-reactive protein-to-albumin ratio levels are associated with osteoporosis in patients with primary biliary cholangitis. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1415488
|
| 19 |
Luciano Colangelo, Federica Biamonte, Jessica Pepe, Cristiana Cipriani, Salvatore Minisola. Understanding and managing secondary osteoporosis. Expert Review of Endocrinology & Metabolism 2019; 14(2): 111 doi: 10.1080/17446651.2019.1575727
|
| 20 |
Jihye Lim, Ye-Jee Kim, Sehee Kim, Jonggi Choi. Increased risk of fragility fractures in patients with primary biliary cholangitis. JBMR Plus 2024; 8(7) doi: 10.1093/jbmrpl/ziae056
|
| 21 |
Mariana de Morais Lira Gouvea SIQUEIRA, Luiz Augusto CASULARI, Wladimir Magalhães de FREITAS, Marcos de Vasconcelos CARNEIRO, Liliana Sampaio Costa MENDES. RISK FACTORS ASSOCIATED WITH FRACTURE OF THE LUMBOSACRAL SPINE AND ITS COMPROMISE IN THE QUALITY OF LIFE OF CIRRHOTICS. Arquivos de Gastroenterologia 2022; 59(1): 9 doi: 10.1590/s0004-2803.202200001-03
|
| 22 |
Christopher J. Danford, Hirsh D. Trivedi, Alan Bonder. Bone Health in Patients With Liver Diseases. Journal of Clinical Densitometry 2020; 23(2): 212 doi: 10.1016/j.jocd.2019.01.004
|
| 23 |
Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling. Primary biliary cholangitis. The Lancet 2024; 404(10457): 1053 doi: 10.1016/S0140-6736(24)01303-5
|
| 24 |
Taiki Mihara, Yoshiharu Tsuru, Tamaki Kurosawa, Yuma Nonoshita, Yuki Yamakawa, Masatoshi Hori. Pemigatinib suppresses liver fibrosis and subsequent osteodystrophy in mice. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000610
|
| 25 |
Zakary Warsop, Nikhil Anand, Husam Al Maliki, Shuell De Souza, Arya Kamyab, Amin Al Hadad, Laith Alrubaiy. Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis. Journal of Personalized Medicine 2024; 14(12): 1133 doi: 10.3390/jpm14121133
|
| 26 |
Jelena Jadzic, Danijela Djonic. Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?. World Journal of Gastroenterology 2023; 29(5): 825-833 doi: 10.3748/wjg.v29.i5.825
|
| 27 |
Yasameen Muzahim, Ali Wakil, Mehak Bassi, Nikolaos Pyrsopoulos. Treatment of Primary Biliary Cholangitis including Transplantation. Clinics in Liver Disease 2024; 28(1): 103 doi: 10.1016/j.cld.2023.07.003
|
| 28 |
Hoang Nam Pham, Linh Pham, Keisaku Sato, Antonio De Vincentis. Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis. PLOS ONE 2023; 18(10): e0292998 doi: 10.1371/journal.pone.0292998
|
| 29 |
Chisato Saeki, Tsunekazu Oikawa, Tomoya Kanai, Masanori Nakano, Yuichi Torisu, Nobuyuki Sasaki, Masahiro Abo, Masayuki Saruta, Akihito Tsubota. Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis. European Journal of Gastroenterology & Hepatology 2021; 33(5): 731 doi: 10.1097/MEG.0000000000001791
|
| 30 |
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
|
| 31 |
Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases. Journal of Autoimmunity 2024; 148: 103289 doi: 10.1016/j.jaut.2024.103289
|
| 32 |
Ivan Arcari, Francesca Colapietro, Nicola Pugliese. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases. Alimentary Pharmacology & Therapeutics 2024; 59(4): 583 doi: 10.1111/apt.17842
|
| 33 |
Christopher J. Danford, Ghideon Ezaz, Hirsh D. Trivedi, Elliot B. Tapper, Alan Bonder. The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Journal of Clinical Densitometry 2020; 23(2): 223 doi: 10.1016/j.jocd.2019.05.003
|
| 34 |
Hae Jeong, Dong Kim. Bone Diseases in Patients with Chronic Liver Disease. International Journal of Molecular Sciences 2019; 20(17): 4270 doi: 10.3390/ijms20174270
|
| 35 |
Kaitlyn Carlson, Madeleine Hines Salge, George Cholankeril. Primary Biliary Cholangitis: Updates in Management and Goals of Treatment. Current Hepatology Reports 2024; 23(3): 349 doi: 10.1007/s11901-024-00667-2
|
| 36 |
Nidah Shabbir Khakoo, Cynthia Levy. The Rose and Mackay Textbook of Autoimmune Diseases. 2024; : 905 doi: 10.1016/B978-0-443-23947-2.00039-4
|
| 37 |
A. Pariente. Colangite (ex cirrosi) biliare primitiva. EMC - AKOS - Trattato di Medicina 2021; 23(2): 1 doi: 10.1016/S1634-7358(21)45043-6
|
| 38 |
Lixia Gao, Li Wang, Elena Woo, XiaoSong He, GaoXiang Yang, Christopher Bowlus, Patrick S.C Leung, M. Eric Gershwin. Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends. Clinical Reviews in Allergy & Immunology 2020; 59(2): 175 doi: 10.1007/s12016-019-08772-7
|
| 39 |
A. Pariente. Colangitis (ex-cirrosis) biliar primaria. EMC - Tratado de Medicina 2021; 25(1): 1 doi: 10.1016/S1636-5410(21)44689-1
|
| 40 |
Johanna Schönau, Axel Wester, Jörn M. Schattenberg, Hannes Hagström. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study. Journal of Internal Medicine 2023; 294(2): 164 doi: 10.1111/joim.13624
|